Novocure (NASDAQ: NVCR) reported Q3 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $50.1 million versus the consensus estimate of $43.55 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.